Biotechnology company MannKind Corp. said Monday that the Food and Drug Administration has requested more information about the inhaled insulin Afrezza, prompting its shares to plummet.
March 15 (Bloomberg) — MannKind Corp. , the biotechnology company run by billionaire inventor Alfred Mann , failed to win approval from U.S. regulators to market its inhaled insulin drug, Afrezza, for people with diabetes.
Syngenta will share information about the use of a new technology that improves efficiency and lowers the cost of genetic data production at the upcoming 52nd Annual Maize Genetic Conference in Riva del Garda, Italy
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.